MENUMENU

Messaging
Tough Questions
Academy
Alerts
Webinars
Topics
- Children and COVID-19
  - Pediatric Vaccines
  - Schools and In-person Learning
  Emergency Declarations
  - End of the PHE
  Emergent Public Health Concerns
  Exposure, Isolation, and Self-Care
  - COVID-19 Exposure or Testing Positive
  - Travel
  Mask Guidance
  - Mask Usage
  - When to Wear a Mask
  Testing, Tracing, and Treatment
  Vaccines
  Variants
  - Omicron
  - New COVID-19 Variants
About
- Brand Ambassador Program
- Meet Our Director
Contact
Subscribe
Toggle website search

Novavax Vaccine

Frequently Asked Questions about Novavax Vaccine

View more FAQs

Children and COVID-19

Pediatric Vaccines
Schools and In-person Learning

Emergency Declarations

End of the PHE

Emergent Public Health Concerns

Mpox (Monkeypox)
Flu
Tripledemic
RSV
Measles (MMR)
H5 Bird Flu
Dengue Virus (DENV)

Exposure, Isolation, and Self-Care

COVID-19 Exposure or Testing Positive
Travel

Mask Guidance

Mask Usage
When to Wear a Mask

Testing, Tracing, and Treatment

Herd Immunity
Testing
Data and Reporting
COVID-19 and the Flu Vaccine
Antiviral Drugs
Contact Notification

Vaccines

Johnson & Johnson vaccine
FDA Approval
"Booster" Doses and Updated Vaccines
Pregnancy and Fertility
Development, Safety, and Effectiveness
Vaccine Mandates
Novavax Vaccine
Vaccine Recommendations

Variants

Omicron
New COVID-19 Variants

About Us
Contact Us
Privacy Policy
Contact (new)
Follow
Twitter
Linkedin

The Public Health Communications Collaborative (PHCC) was formed in 2020 to coordinate and amplify public health messaging on COVID-19 and increase Americans' confidence in guidance from the Centers for Disease Control and Prevention (CDC) and state and local public health officials. See more information, including partners.

Close Menu

Get Updates

Messaging resources, misinformation alerts, webinars, and more—all designed to support you to effectively communicate about public health issues.

Academy